Global Topical Drug Delivery Market: Emerging Trends, Major Key Players Johnson & Johnson (US) and Nestlé SA (Switzerland)

According to the report, The topical drug delivery market is projected to reach USD 129.8 billion by 2025 from USD 95.2 billion in 2020, at a CAGR of 6.4% from 2020 to 2027. The major driver for the Topical Drug Delivery Market is increasing numbers of people suffering from acne or other skin conditions. Strides in medical research mean that there are more drugs available to help people with a range of problems relating to their skin. Topical drug delivery systems do not get filtered out by the liver and kidneys, which means they can be used for a wide range of ailments that affect the skin. Other top drivers include the increase in demand from developed nations and research into improving formulations to get better results.

Request Free Sample Report or PDF Copy: https://report.evolvebi.com/index.php/sample/request?referer=OpenPR&reportCode=006168

The latest research report published by Evolve Business Intelligence examines the impacts of numerous market aspects on the global TOPICAL DRUG DELIVERY industry including a look at the current market size and forecasts for key segments and regions, the driving forces behind the market, the probable effects from key trends, how all these will affect the business plan, SWOT analysis of critical sectors for each of the key competitors, customers and more! Providing valuable data about conglomerations that are most likely going to have an impact on this industry is essential to any company who plans to properly invest for next 5 years. These findings supplement our initial quantitative study in order to facilitate any new investments or planning traits against threats in existing sectors through a strategic business plan.

Impact of COVID-19

The on-going COVID-19 pandemic has had a significant impact on the industry. Several financial impacts and disruptions have been felt over a long period of time. Our research has interviewed numerous delegates from this industry, across geographical markets to collect information that is helpful for addressing potential challenges the COVID-19 pandemic may cause going forward.
In terms of COVID 19 impact, the Topical Drug Delivery market report also includes the following data points:
• Impact of COVID-19
• Government Aids and Policies for Industry Revival
• Companies Recent Developments to Tackle Negative Impact
• Opportunity Window & Post COVID Trend

For Any Query or Customization, Ask Our Industry Experts@ https://report.evolvebi.com/index.php/sample/request?referer=OpenPR&reportCode=006168

Key Players
Some of the major Topical Drug Delivery players holding highest market share include Johnson & Johnson (US), Nestlé SA (Switzerland), Novartis AG (Switzerland), GlaxoSmithKline (UK) and Bausch Health Companies (Canada). These players use new product development as a key strategy to gain significant market share to compete with market leaders.

The key players profiled in the report are:
• Johnson & Johnson (US)
• Nestlé SA (Switzerland)
• Novartis AG (Switzerland)
• GlaxoSmithKline (UK)
• Bausch Health Companies (Canada)
• Merck & Co (US)
• Bayer AG (Germany)
• Hisamitsu Pharmaceutical (Japan)
• Glenmark Pharmaceuticals (India)
• Cipla Ltd (India)
• Crescita Therapeutics Inc. (Canada)
• Mylan (US)

Segmental Analysis

Market Segment By Product with focus on market share, consumption trend, and growth rate of TOPICAL DRUG DELIVERY Market:
• Semi-Solid Formulations
• Semi-Solid Formulations
• Solid Formulations
• Transdermal Products

Market Segment By Route of Administration with focus on market share, consumption trend, and growth rate of TOPICAL DRUG DELIVERY Market:
• Dermal Drug Delivery
• Ophthalmic Drug Delivery
• Rectal Drug Delivery
• Vaginal Drug Delivery
• Nasal Drug Delivery

Market Segment By Facility of Use with a focus on market share, consumption trend, and growth rate of TOPICAL DRUG DELIVERY Market:
• Home Care Settings
• Hospitals & Clinics
• Burn Centers
• Other Facilities

For more information: https://report.evolvebi.com/index.php/sample/request?referer=OpenPR&reportCode=006168

Global Topical Drug Delivery Geographic Coverage:
• North America
o US
o Canada

• Europe
o UK
o Germany
o France
o Italy
o Spain
o Rest of Europe

• Asia Pacific
o China
o Japan
o India
o South Korea
o Indonesia
o Malaysia
o Rest of Asia Pacific

• Latin America
o Mexico
o Brazil
o Argentina
o Rest of Latin America

• Middle East & Africa
o Saudi Arabia
o UAE
o Egypt
o South Africa
o Rest of MEA

Address
Evolve Business Intelligence
C-218, 2nd floor, M-Cube
Gujarat 396191
India

Contact: +1 773 644 5507 / +91 635 396 3987
Email: sales@evolvebi.com
Website: https://evolvebi.com/

About EvolveBI
Evolve Business Intelligence is a market research, business intelligence, and advisory firm providing innovative solutions to challenging pain points of a business. Our market research reports include data useful to micro, small, medium, and large-scale enterprises. We provide solutions ranging from mere data collection to business advisory.

Evolve Business Intelligence is built on account of technology advancement providing highly accurate data through our in-house AI-modelled data analysis and forecast tool – EvolveBI. This tool tracks real-time data including, quarter performance, annual performance, and recent developments from fortune’s global 2000 companies.

This release was published on openPR.